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Abstract
Background: Research that examines the quality of home health care is complex because no gold
standard exists for measuring adverse outcomes, and because the patient and clinician populations
are highly heterogeneous. The objectives in this study are to develop models to predict functional
decline for three indices of functional status as measures of adverse events in home health care and
determine which index is most appropriate for risk-adjusting for future quality research.
Methods: Data come from the Outcomes and Assessment Information Set (OASIS) from a large
urban home health care agency and other agency data. Prognostic data yields 49,437 episodes,
while follow-up data yields 47,684 episodes. We tested three indices defined as substantial decline
in three or more (gt3_ADLs), two or more (gt2_ADLs), and one or more (gt1_ADLs) ADLs.
Multivariate logistic regression determines the performance of the models for each index as
measured by the c-statistic and Hosmer-Lemeshow chi square (χ2).
Results: Frequencies for gt3_ADLs, gt2_ADLs, and gt1_ADLs are 212 (0.43%), 783 (1.58%), and
4,271 (8.64%) respectively. Follow-up results are comparable with frequencies of 218 (0.46%), 763
(1.60%), and 3,949 (8.28%) for each index. Gt3_ADLs does not produce valid models. The model
for gt2_ADLs consistently yields a higher c-statistic compared to gt1_ADLs (0.754 vs. 0.679,
respectively). Both indices' models yield non-significant Hosmer-Lemeshow chi square indicating
reasonable model fit. Findings for gt2_ADLs and gt1_ADLs are consistent over time as indicated
by follow-up data results.
Conclusion: Gt2_ADLs yields the best models as indicated by a high c-statistic and a non-
significant Hosmer-Lemeshow χ2, both of which exhibit exceptional consistency. We conclude that
gt2_ADLs may be preferable in defining ADL adverse events in the context of home health care.
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Background
Research that examines the quality of home health care is
complex because no gold standard exists for measuring
adverse events, and because the patient and clinician pop-
ulations are highly heterogeneous. In 1999, the Center for
Medicare and Medicaid Services (CMS) instituted the use
of the Outcomes and Assessment Information Set
(OASIS) for all home health care agencies to be used for
internal and external quality assessment. In October of
2000, OASIS measures also became the basis for case-mix
adjustment in a new home health care prospective pay-
ment system. Shaughnessy et al. developed a comprehen-
sive framework using a two-stage process for assessing the
quality of home health care which separates the effects of
natural disease progression from the effects of substand-
ard care. The process and the measures they developed
were used by CMS as the model on which to base home
health care quality improvement [1,2]. As part of its out-
comes based quality initiative, CMS identifies 13 poten-
tial adverse events for patients in home health care.
Adverse events are considered to be both rare and poten-
tially preventable through provision of appropriate
skilled care. The adverse events cover four main areas:
emergency care, serious unexpected events, unmet care
needs, and declines in health or physical functioning [3].
Declines in health or physical function refer to changes in
the ability to perform activities of daily living (ADL) and
instrumental activities of daily living (IADL) [4]. Measures
of ADLs include basic tasks like being able to feed, bathe,
and groom oneself, while IADLs involve life skills such as
cooking and cleaning. Some researchers have cited the
measure of ADLs as the most important outcome for
measurement for individuals receiving long term care and
hence, home care [5]. Currently, CMS considers declining
ADL function to be an adverse event if a home health
patient experiences a "substantial decline in three or more
ADLs", where substantial is considered a minimum two-
unit decline from the start of home health care to final dis-
charge, regardless of the time frame [1,2]. The five ADLs
included in the index are grooming, toileting, bathing,
transferring, and ambulation. OASIS is unique in that it
does not have each skill measured on the same scale and
some skills allow for use of medical devices for assistance
while others do not include devices (see Table 1). CMS
provides public reporting for changes in discrete func-
tional status items through the Medicare website; these
items are risk adjusted as part of the public reporting func-
tion. However, the adverse event reports are not risk
adjusted, primarily because the intent is that these adverse
events are to be investigated at the patient level to deter-
mine whether there are overall quality improvement
measures to be taken by the agency.
In this paper, we evaluate three indices of ADL decline
among home health patient episodes of care at a large
metropolitan home health care agency. One index is cal-
culated in a comparable fashion to the one currently used
by CMS, described above. Based on empirical and theoret-
ical considerations, two additional indices are developed.
The main question is whether the CMS definition is the
most appropriate ADL index for defining adverse events in
the context of home health care. A secondary question is
the degree to which the indices may be affected by floor
effects that may lead to biased results [6].
Methods
The data consist of episodes of patient care derived from
two separate six-month periods, the first of which is used
to derive the analysis sample, with the second providing a
follow-up sample for evaluating consistency over time.
The same six months from adjacent years are used to min-
imize any seasonal bias across samples. This study is
based on deidentified data and as such was granted
exemption from ethical review by Case Western Reserve
University.
The start of any given episode of care is defined as the first
recorded OASIS assessment during the sample time frame
for start of care or resumption of care. Resumption of care
occurs when patients are returning to home health care
after a transfer to an institutional setting. The end of a
given episode of care is defined as the first discharge
OASIS assessment occurring on or before 60 days follow-
ing the start of the episode; if no discharge has occurred by
60 days, the closest OASIS assessment available at or
before 60 days is used. Following the implementation of
the home health prospective payment system for Medi-
care home health, CMS required agencies to conduct
OASIS assessments every 60 days for patients still in care.
Thus, the maximum length for an individual episode is 60
days. Because the time frames for each sample is 6
months, patients may experience multiple episodes
within a sample.
Sample
There were a total of 54,732 and 51,560 patient episodes
for the prognostic and follow-up datasets, respectively. Of
these, 5,295 were excluded from the prognostic dataset
and 3,876 were excluded from the follow-up dataset
because they did not have outcome data (e.g. died, hospi-
talized) yielding a total of 49,437 and 47,684 episodes of
care, respectively for the prognostic and follow-up data-
sets (see Figure 1).
Dependent variables
As a first step to developing alternatives to the conserva-
tive CMS-based index, we evaluate two-unit change fre-
quencies for each individual ADL (e.g., minimum two-BMC Health Services Research 2006, 6:162 http://www.biomedcentral.com/1472-6963/6/162
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unit declines in each category: grooming, toileting, bath-
ing, transferring, and bathing). Incremental change for a
one-unit decline for the five ADLs and for a three-unit
decline for the five ADLs are also evaluated. These univar-
iate analyses are done for two reasons:
￿ to determine which ADLs are driving the indices (i.e.,
comprising the largest frequency);
￿ to evaluate the frequencies of the magnitude of func-
tional decline (e.g., to determine if most of the declines
were one unit, two-unit, or three unit changes).
The univariate analyses provide additional information.
The nature of home health care agencies allows for many
nurses and practitioners to provide care. Therefore, a one-
unit change is not considered enough of a difference since
it may be attributable to different clinicians' views of
dependency and hence may lead to more measurement
error. While physical functioning skills are considered
among the most reliable outcome measures in the OASIS
[7-9], a one-unit change may be attributable to measure-
ment error based on clinical judgment and the methods
by which the data are coded (i.e. observation versus inter-
view).
Table 1: Definition of Individual ADLs and ADL Scales on OASIS
ADL Definition of Values
ADL: Grooming* 0 = Able to groom self unaided, with or without use of assistive devices
1 = Grooming utensils must be placed within reach
2 = Someone must assist the patient to groom self
3 = Patient depends entirely upon someone else
ADL: Ability to dress upper body 0 = Able to obtain, put on, and remove clothing
1 = Able to dress upper body without assistance
2 = Someone must help patient
3 = Patient depends entirely on someone else
ADL: Ability to dress lower body 0 = Able to obtain, put on and remove clothing
1 = Able to dress lower body without assistance
2 = Someone must help the patient
3 = Patient depends entirely on someone else
ADL: Bathing* 0 = Able to bathe self in shower or tub independently
1 = With the use of devices, is able to bathe
2 = Able to bathe with the assistance of a person
3 = Participates in bathing in shower or tub
4 = Unable to use the shower or tub, but able to assist
5 = Unable to effectively participate in bathing, totally bathed by another person
ADL: Toileting* 0 = Able to get to and from the toilet independently
1 = When reminded assisted or supervised
2 = Unable to get to and from toilet; can use bedside commode
3 = Unable to get to from the toilet or bedside commode; can use a bedpan
4 = Is totally dependent for toileting
ADL: Transferring* 0 = Able to independently transfer
1 = Transfers with minimal human assistance
2 = Unable to transfer self but is able to bear weight
3 = Unable to transfer self and is unable to bear weight
4 = Bedfast, unable to transfer but is able to turn
5 = Bedfast, unable to transfer and is unable to turn
ADL: Ambulation/Locomotion* 0 = Able to independently walk
1 = Requires use of a device
2 = Able to walk only with the supervision
3 = Chairfast, unable to ambulate but can use wheelchair
4 = Chairfast, unable to ambulate and or use wheelchair
5 = Bedfast
ADL: Feeding or eating 0 = Able to independently feed self
1 = Able to feed self but requires help in setup
2 = Unable to feed self and requires human assistance
3 = Able to take in nutrients orally and tube fed
4 = Unable to take in nutrients orally; tube fed
5 = Unable to take in nutrients orally or by tube feeding
*Indicates this ADL was included in all three of the ADL indices.BMC Health Services Research 2006, 6:162 http://www.biomedcentral.com/1472-6963/6/162
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When evaluating declines in three or more ADLs exhibit-
ing a three-unit change, the frequencies are extremely low
(less than 0.20 percent). Declines in two or more ADLs
exhibiting a three-unit decline are more frequent (more
than 0.50 percent) but, still very small and incapable of
providing meaningful statistical analyses. A three-unit
decline is considered to be too large of a change, resulting
in even fewer episodes experiencing ADL declines. Conse-
quently, for all three indices, substantial indicates a mini-
mum two-unit decline.
In addition to the incremental change issues aforemen-
tioned, another issue is the number of ADLs which need
to have a substantial decline, where substantial is a mini-
mum two-unit decline. One of the alternative indices is
defined as substantial decline in two or more ADLs and is
referred to as gt2_ADLs. A second alternative index is
defined as substantial decline in one or more ADLs and is
referred to as gt1_ADLs.
Independent variables
There were 112 available covariates (including referent
categories) between OASIS and other agency administra-
tive data. These covariates fall into seventeen main catego-
ries. The number in parentheses indicates the number of
covariates for each category. The constructs are: demo-
graphics (11), physician availability (2), financial factors
(4), language (3), payment source (5), referral and per-
sonal health at baseline (16), pain assessment (4), integ-
umentary status (3), respiratory status (1), sensory status
(3), elimination status (5), housing and living arrange-
ments (4), support and assistance in the home (8), neuro-
logical/behavioral/emotional status (5), medication
assessment (7), ICD-9 primary diagnosis codes (22), ICD-
9 primary diagnosis codes for the main diagnoses for this
particular home health care agency (9). Physician availa-
bility is defined as the number of physicians available per
100,000 people per zip code and is divided into quintiles.
Univariate analyses
Because it is unclear which of the five ADLs is most appro-
priate, it is not desirable to use an individual ADL out-
come [10,11]. However, incremental changes in ADLs are
evaluated to determine if any specific ADL is a major con-
tributor for declines experienced in the indices. An addi-
tional concern when examining ADL outcomes is the
number of cases excluded due to 'floor' effects. If an ADL
as measured at the start of an episode is already at a level
of functioning such that it is impossible for a decline to be
identified by an index, it is dropped from consideration.
Excluded Episodes from Prognostic and Follow-Up Datasets Figure 1
Excluded Episodes from Prognostic and Follow-Up Datasets. *CMS made coding changes in 2002 which accounts for 
this difference between the prognostic and follow-up datasets. Despite this difference, the datasets are similar with regard to 
included episodes.BMC Health Services Research 2006, 6:162 http://www.biomedcentral.com/1472-6963/6/162
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However, this introduces a potential bias in excluding
from the calculation of the respective indices those epi-
sodes beginning with greater severity in ADL functioning.
Thus, gt3_ADLs can only be calculated for episodes that
begin with the possibility of worsening in three of the five
ADLs; therefore, episodes at the 'floor' for gt3_ADLs are
those unable to worsen in three or more ADLs. Likewise,
for gt2_ADLs, 'floor' episodes are unable to worsen in at
least four ADLs; and 'floor' episodes for gt1_ADLs are una-
ble to decline in any of the ADLs.
Multivariate analyses
We estimate a series of multivariate logistic regression
models using SAS version 8.0 [12]. Variables included in
the initial models are selected among the full set of inde-
pendent measures, using three criteria: 1) a minimum of
5% frequency criterion; 2) risk factors with a correlation
of 0.80 or higher presumably measure the same item [13]
and when this occurs, one of the variables is randomly
eliminated; and 3) bivariate analyses including the
weighted baseline ADL status [14] due to its well docu-
mented association with functional decline [15-17], with
p < 0.10 used as the selection criterion because the associ-
ation between functional decline and many risk factors is
unclear. Baseline ADL scores are weighted by dividing the
score for each individual ADL by the total possible and
then the five weighted scores are summed [18]. In the
final step, forward stepwise multivariate logistic regres-
sion is configured to use a selection criterion of p < 0.05
[19].
Analytical measures
For the multivariate logistic regression analyses, the c-sta-
tistic and the Hosmer-Lemeshow Goodness of Fit test are
compared for each model. The c-statistic, calculated as the
area under the Receiver Operating Characteristic (ROC)
curve, represents the concordance between predicted
probabilities and observed outcomes for all possible pairs
of patients [20,21]. A c-statistic of 1.0 indicates perfect
predictive discrimination while a value of 0.50 indicates
the model performs no better than chance alone. A c-sta-
tistic over 0.70 is considered acceptable while values
higher than 0.80 are considered excellent [22].
The Hosmer-Lemeshow Goodness of Fit test examines
model calibration across a range of predicted probabilities
[13], producing a single summary measure of the match
between predicted and actual outcomes within deciles of
the data. Within each decile, deviations between observed
and expected number of declines in functional status are
observed and expected numbers of episodes not experi-
encing functional decline are measured. In order to deter-
mine whether these deviations are larger than expected,
these deviations are summed over the ten groups and
compared to a χ2 with 8 degrees of freedom [22]. For the
Hosmer-Lemeshow test, a p-value that is not statistically
significant is indicative of reasonable model fit. Consist-
ency over time is assessed by comparing the models'
results from the prognostic and follow-up datasets.
Results
For the prognostic data, the population of episodes aver-
ages 71 years of age with 68% being female. The popula-
tion is highly diverse: 36% white, 26% black, 26%
Hispanic, 5% Asian, and 7% some other ethnicity. Clini-
cal diagnoses cover a wide spectrum of conditions, with
the most common being dyspnea (48%), circulatory dis-
eases (28%), and skin lesions (24%). In general, com-
pared to the entire dataset, the subsets of episodes
experiencing substantial functional decline tend to have a
larger proportion of the following: women, older patients,
Black patients, low physician availability, low income,
more comorbidities, and episodes covered by both Medi-
care and Medicaid health insurance. The follow-up data
has similar demographic characteristics.
Gt3_ADLs, defined as substantial decline in three or more
ADLs, consistently yields the lowest frequencies with
results of 212 and 218 respectively for the prognostic and
follow-up datasets (see Table 2). This conservative index
only accounts for half a percent of either dataset.
Gt2_ADLs, defined as substantial decline in two or more
ADLs and gt1_ADLs, defined as substantial decline in one
or more ADLs, yields substantially more frequent occur-
rences of decline. Gt2_ADLs yields frequencies of 783 and
763 respectively for the prognostic and follow-up data-
sets, accounting for about 2% of all episodes. Gt1_ADLs
yields frequencies of 4,271 and 3,949 respectively for the
prognostic and follow-up datasets, accounting for nearly
9% of all the episodes. All three indices exhibit stability
with comparable frequencies in the prognostic and fol-
low-up datasets.
We conclude that we have no 'floor' effects for gt1_ADLs
or gt2_ADLs because the results are comparable with and
without 'floor' covariates. Interaction is assessed and
determined not to be present. Gt3_ADLs models do not
converge, resulting in spurious results that are not shown.
The model for gt2_ADLs yields a c-statistic of 0.754 for the
prognostic dataset; this is consistent with a c-statistic of
0.744 for the follow-up dataset (see Table 3). This repre-
sents only a 1% difference in the model's predictive abil-
ity. The Hosmer-Lemeshow χ2 is 10.370 with a p-value of
0.240, indicating reasonable model fit. These results are
supported with the follow-up data (χ2 statistic with 8
degrees of freedom was 9.437 with a p-value of 0.307).
The models for gt2_ADLs have 24 and 19 significant cov-
ariates for the prognostic and follow-up datasets, respec-
tively.BMC Health Services Research 2006, 6:162 http://www.biomedcentral.com/1472-6963/6/162
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The c-statistics from models of gt1_ADLs are substantially
lower at 0.679 and 0.683 for the prognostic and follow-up
datasets, respectively (see Table 3). The Hosmer-Leme-
show χ2 is 9.781 with a p-value of 0.281, indicating rea-
sonable model fit. The follow-up data results are
comparable (χ2statistic with 8 degrees of freedom is
10.090 with a p-value of 0.259). The models for gt1_ADLs
have 32 and 26 significant covariates for the prognostic
and follow-up datasets, respectively.
Table 4 shows the regression results for gt2_ADLs and
gt1_ADLs for both datasets. While some inconsistencies
are evident among covariates that are significant in the
prognostic dataset and not the follow-up dataset, all of the
associations are consistent (i.e., covariates positively asso-
ciated with declines in the prognostic data are also posi-
tively associated with declines in the follow-up data;
negatively associated covariates for prognostic are also
negatively associated for follow-up). Covariates that yield
the strongest associations (positive or negative) are con-
sistent across time periods (e.g., lowest physician availa-
bility, elimination status problems; daily pain, dyspnea,
and surgical wounds).
Discussion
Across the prognostic and follow-up datasets, simple fre-
quencies of ADL adverse events were similar for all three
indices. All three indices are most influenced by the sub-
stantial decline in the ADL for bathing. Declines in bath-
ing may be most frequent due to the difficulty of
independent use of showers and bathtubs for elderly,
infirm patients.
Gt3_ADLs, which is based on the current CMS definition
of an ADL adverse event, was too conservative, yielding
few episodes experiencing functional decline and numer-
ous 'floor' episodes as compared to the alternative indices.
However, there are also benefits to using gt3_ADLs. Con-
tinuing to use the implementation of the CMS defined
ADL index promotes consistency in process of care inves-
tigations across the home health care industry. Further-
more, this index is infrequent enough to be considered
rare, a caveat of being an adverse event. However, when
events are very rare, determining the root cause of prob-
lems is difficult. Likewise, it is difficult to evaluate if
implemented solutions have been effective with rare
events.
Table 3: Summary of Analytical Measures
Prognostic Models Follow-Up Models
Measure Gt2_ADLs Gt1_ADLs Gt2_ADLs Gt1_ADLs
c-statistic 0.754 0.679 0.744 0.683
# significant covariates 24 32 19 26
H-L Χ2 (8 d.f.)* 10.370 9.781 9.437 10.090
p-value 0.240 0.281 0.307 0.259
*Hosmer-Lemeshow chi square with 8 degrees of freedom.
Table 2: Descriptive Statistics for Individual ADLs, ADL Indices, and 'Floors'
Prognostic Frequency Prognostic 'Floors' Prognostic Total n* Follow-Up Frequency Follow-Up 'Floors' Follow-Up Total n*
Outcome n 
(%)
n
(%)
nn
(%)
n
(%)
n
Gt3_ADLs 212
(0.47%)
4 657
(9.4%)
44780 218
(0.50%)
4 217
(8.8%)
43467
Gt2_ADLs 783
(1.69%)
3 203
(6.5%)
46234 763
(1.71%)
2 968
(6.2%)
44716
Gt1_ADLs 4 271
(8.98%)
1 896
(3.8%)
47541 3 949
(8.60%)
1 757
(3.7%)
45927
Grooming 904
(2.74%)
16 482
(33.3%)
32955 867
(2.70%)
15 577
(32.7%)
32107
Bathing 2 133
(4.81%)
7 802
(15.8%)
44307 1 939
(4.78%)
7 093
(14.9%)
40591
Toileting 911
(2.19%)
5 130
(10.4%)
41635 842
(1.96%)
4 700
(9.9%)
42984
Transferring 728
(1.54%)
2 138
(4.3%)
47299 708
(1.55%)
2 024
(4.2%)
45660
Ambulation 675
(1.48%)
3 933
(8.0%)
45504 652
(1.48%)
3 569
(7.5%)
44115
*n varies for each outcome since the number of episodes at the 'floor' varies.BMC Health Services Research 2006, 6:162 http://www.biomedcentral.com/1472-6963/6/162
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Table 4: Prognostic and Follow-Up Model Results for Gt2_ADLs and Gt1_ADLs
Prognostic Models Follow-Up Models
Parameter Gt2_ADLs Gt1_ADLs Gt2_ADLs Gt1_ADLs
Only Significant Odds Ratios (OR) Reported OR OR OR OR
Demographics
Female
Age 75 to 84 0.84
Age 85 and over 1.34 1.12 1.28
White
Non-White 1.11
Physician Availability
Highest quintile of availability 0.73
Lowest quintile of availability 1.30 1.17 1.30 1.18
Financial Factors
Highest quintile of income
Lowest quintile of income 1.26 1.24 1.13
Financial Difficulties
Language
Spanish speaking only
Translator needed 0.87
Payment Source
Medicaid
Medicare and Medicaid
Private or other payer 0.62 0.73 0.69
Managed care 0.65
Living Arrangements
Lives alone 0.82 0.84
Lives with spouse
Lives with Family 1.10 1.12
Support/Assistance
Assistance, none 1.41 1.20
Assistance in place of residence
Assistance, out of residence
Caregiver is spouse
Pain Status
pain, daily 0.76 0.84 0.82 0.87
Intractable pain
Referral/Personal Health
comorbidities (mean) 1.06 1.08
Discharged from hospital within two weeks prior to admittance 0.75 0.80 0.80
Discharged from other facility within two weeks prior 0.82 0.80
Referral from a public hospital 1.43 1.18
Life expectancy 2.02 1.42
Medical regimen change within two weeks prior 0.89 0.69 0.87BMC Health Services Research 2006, 6:162 http://www.biomedcentral.com/1472-6963/6/162
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Obesity 0.73
Primary Diagnosis Severity
Referral/Personal Health
Poor prognosis 1.78 1.24 1.30
Poor rehabilitation 1.13 1.37
High Risk Factor Summary Score
Smoking
Weighted ADL Summary Score 1.25 1.07 1.18 1.06
Sensory Status
Vision impairment 1.13
Hearing impairment 0.66 0.85 0.87
Speech impairment 1.39 1.46 1.39
Elimination Status
Urine incontinence 1.86 1.46 1.87 1.45
Urinary catheter 2.80 1.86 1.73 1.69
Bowel incontinence 1.63 1.33 1.83 1.65
Incontinence
Neurological/emotional
Cognitive impairment, mild
Cognitive impairment, high
Confusion
Depressed
Medication Assessment
unique number of drugs (mean)
number of drug classes (mean)
Psychotropic drug usage
Caregiver knowledgeable of Medications 1.13 1.12
ICD9 Codes of Primary Diagnosis
Circulatory without COPD
Dyspnea 0.85 0.86 0.79 0.89
Injury 0.79
Musculoskeletal 0.71 0.77 0.82
Neoplasm 1.47 1.29 1.92 1.26
nervous system diseases 1.67 1.38 1.38 1.34
Respiratory diseases
skin diseases 1.38 1.39
Skin lesion 1.15
Surgical wound 0.70 0.71 0.62 0.67
Among top ICD9 codes for agency
Congestive Heart Failure 1.25
Pressure Ulcer 1.56 1.28 2.19 1.50
OR stands for Odds Ratio
All odds ratios reported were significant at p < .05
Table 4: Prognostic and Follow-Up Model Results for Gt2_ADLs and Gt1_ADLs (Continued)BMC Health Services Research 2006, 6:162 http://www.biomedcentral.com/1472-6963/6/162
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The proposed indices gt1_ADLs and gt2_ADLs offer
advantages of their own. The gt1_ADLs models adhere to
the '×10' guideline and is consistent with the high part of
the range (4–8%) often found in the hospital literature
[23-26]. However, gt1_ADLs may be too frequent to be
considered rare, a necessary attribute of adverse events
with ~10% of patients experiencing such an event.
Gt2_ADLs adheres to the '×10 rule' [27], a statistical
guideline advising a dichotomous outcome to be, at min-
imum, ten times as large as the number of covariates
being analyzed. The entire dataset has 112 covariates;
prognostic and follow-up data result in 783 and 763 epi-
sodes respectively, just slightly under this recommenda-
tion.
There may be several important policy and clinical impli-
cations of implementing the use of gt2_ADLs as an ADL
index for defining adverse events in the context of home
health care. While still considered rare (less than 2% of
the entire population), gt2_ADLs is more frequent and by
definition, less restrictive. Requiring the decline of only
two ADLs compared to three (e.g. gt3_ADLs), gt2_ADLs
encompasses both a larger frequency of episodes and a
population experiencing slightly less functional decline
and hence, one less likely to have episodes at the "floor"
at baseline. A slightly larger and less incapacitated popu-
lation may provide more valid results for both case-mix
and for evaluating changes in clinical and/or policy prac-
tices.
Limitations
The OASIS dataset utilized in this study represents the
population of episodes for the largest not-for-profit home
health care agency in the United States, but is not neces-
sarily representative of the vast majority of home health
care agencies nationwide. For this reason, these results are
not generalizable to other home health care agencies. As
well, the size of this one agency, as compared to smaller
agencies, may mean that our results are more stable in
comparison to smaller agencies. A second limitation is the
use of a different calculation from CMS in developing the
indices. The CMS definition does not include any time
restriction in comparison to our 60-day limit. We would
anticipate our definition to capture declines in functional
status more quickly as episodes are reassessed in shorter
time periods. Therefore, we may be increasing the number
of episodes considered "floors".
Another limitation is the way in which the information is
compiled; the datasets used are unable to be linked, mak-
ing it impossible to know whether patients in the prog-
nostic data are also in the follow-up data. The assumption
was that these are independent samples for analytical pur-
poses. Furthermore, patients within each dataset may
have been represented more than one time. The unit of
analysis was episode of care defined as a maximum of
sixty days. This could bias results as patient health charac-
teristics could be correlated from one episode to another
[28]. However, 67% of the patients were on their first epi-
sode. There was an average 1.5 episodes per patient mak-
ing correlated episodes an unlikely source of bias.
From an analytical standpoint, it may have been advanta-
geous to use a multinomial model to deal with the issue
of competing risks (i.e. more episodes were excluded due
to admittance to a hospital or other inpatient facility than
experienced the functional decline). However, a multi-
nomial model was developed and failed to converge.
Conclusion
The models for gt2_ADLs provide the most valid index for
predicting patients that will experience functional decline.
This conclusion is based on criteria of c-statistics above
0.70; non-significant Hosmer-Lemeshow χ2  indicating
reasonable model fit, and the requirement of fewer covari-
ates to produce valid models indicative of greater effi-
ciency as compared to gt1_ADLs. These results are proven
reliable with comparable follow-up data results.
The use of gt2_ADLs for defining ADL adverse events in
home health care results in a slightly larger and less inca-
pacitated population which may be more appropriate for
case-mix adjustment and evaluating changes imple-
mented in clinical and/or policy practices. However, this
study provides only a first step in evaluating these adverse
event indicators. Further research is necessary to assess the
ability of these indices to be used in case-mix adjustment
for evaluating quality in home health care. As well, the
larger question of the quality of care in home health care
using these measures remains unanswered–comparisons
of these functional status measures with other external
appraisals of quality would contribute valuable informa-
tion in home health care quality research.
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